Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-08

FDA Approved: EVOXAC — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for EVOXAC (cevimeline hydrochloride) by Cosette Pharmaceuticals, Inc. The action provides supplemental approval for the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVOXAC (cevimeline hydrochloride)

Snippet

SUPPL AP for EVOXAC (CEVIMELINE HYDROCHLORIDE)